[go: up one dir, main page]

NO911216D0 - Fremgangsmaate for fremstilling av farmasoeytisk aktive piroksikam/syklodekstrin-komplekser. - Google Patents

Fremgangsmaate for fremstilling av farmasoeytisk aktive piroksikam/syklodekstrin-komplekser.

Info

Publication number
NO911216D0
NO911216D0 NO911216A NO911216A NO911216D0 NO 911216 D0 NO911216 D0 NO 911216D0 NO 911216 A NO911216 A NO 911216A NO 911216 A NO911216 A NO 911216A NO 911216 D0 NO911216 D0 NO 911216D0
Authority
NO
Norway
Prior art keywords
complexes
piroxicam
pharmasoyytic
extrine
cyclode
Prior art date
Application number
NO911216A
Other languages
English (en)
Other versions
NO178456B (no
NO178456C (no
NO911216L (no
Inventor
Fabio Carli
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO911216D0 publication Critical patent/NO911216D0/no
Publication of NO911216L publication Critical patent/NO911216L/no
Publication of NO178456B publication Critical patent/NO178456B/no
Publication of NO178456C publication Critical patent/NO178456C/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO911216A 1990-03-27 1991-03-25 Fremgangsmåte for fremstilling av farmasöytisk aktive piroksikam/syklodekstrinkomplekser NO178456C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19829A IT1241088B (it) 1990-03-27 1990-03-27 Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche

Publications (4)

Publication Number Publication Date
NO911216D0 true NO911216D0 (no) 1991-03-25
NO911216L NO911216L (no) 1991-09-30
NO178456B NO178456B (no) 1995-12-27
NO178456C NO178456C (no) 1996-04-03

Family

ID=11161628

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911216A NO178456C (no) 1990-03-27 1991-03-25 Fremgangsmåte for fremstilling av farmasöytisk aktive piroksikam/syklodekstrinkomplekser

Country Status (24)

Country Link
US (1) US5164380A (no)
EP (1) EP0449167B1 (no)
JP (1) JPH04221314A (no)
KR (1) KR0175934B1 (no)
AT (1) ATE157883T1 (no)
AU (1) AU644417B2 (no)
CA (1) CA2039052C (no)
CZ (1) CZ280164B6 (no)
DE (1) DE69127566T2 (no)
DK (1) DK0449167T3 (no)
ES (1) ES2107430T3 (no)
FI (1) FI102461B1 (no)
GR (1) GR3025305T3 (no)
HU (1) HU217834B (no)
IE (1) IE910969A1 (no)
IL (1) IL97693A (no)
IT (1) IT1241088B (no)
MA (1) MA22089A1 (no)
NO (1) NO178456C (no)
NZ (1) NZ237583A (no)
PT (1) PT97176B (no)
RU (1) RU2034544C1 (no)
SK (1) SK279171B6 (no)
ZA (1) ZA912282B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254541A (en) * 1991-11-15 1993-10-19 Merck Frosst Canada, Inc. (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
IT1295289B1 (it) * 1997-10-07 1999-05-04 Telos S R L Co-macinati per uso cosmetico e dermatologico
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
WO1999061001A1 (en) 1998-05-29 1999-12-02 Rtp Pharma Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
SK288117B6 (sk) * 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
US20060073188A1 (en) * 1999-03-31 2006-04-06 Pierre Fabre Medicament Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
ITMI20012749A1 (it) * 2001-12-21 2003-06-21 Chiesi Farma Spa Procedimento per la preparazione mediante trattamento con microonde di composti di inclusione tra farmaco e ciclodestrine e prodotti ottenut
FR2868315B1 (fr) * 2004-04-01 2006-07-14 Pierre Fabre Medicament Sa Procede de preparation d'un compose d'inclusion soluble de substances actives dans une molecule hote avec l'aide d'un agent d'interaction par fluide supercritique
ES2424235T3 (es) 2004-04-01 2013-09-30 Pierre Fabre Medicament Complejos de inclusiones que comprenden piroxicam, una ciclodextrina y arginina
US8715731B2 (en) * 2006-03-22 2014-05-06 Isp Investments Inc. Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin
JP5552400B2 (ja) * 2010-09-07 2014-07-16 東亜薬品株式会社 生薬類の苦味・不快味をマスキングした顆粒剤、及び口腔内速崩壊錠
CN102008450B (zh) * 2010-12-10 2013-01-30 杭州艾瑞莎生物医药科技有限公司 一种药物-环糊精纳米颗粒及其制备方法
ITMI20120092A1 (it) 2012-01-26 2013-07-27 Micro Macinazione S A Compositi di inclusione farmaco-carrier preparati con processo di attivazione meccano-chimica mediante mulini a getto di fluido ad alta energia
ITUB20161027A1 (it) * 2016-02-24 2017-08-24 Altergon Sa Preparazioni farmaceutiche oromucosali ad elevata biodisponibilita’ a base di ciclodestrina e sucralosio
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
KR102337124B1 (ko) * 2021-05-13 2021-12-10 (주)바이오제닉스 탈모 개선용 복합 파우더 및 이를 포함하는 모발용 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
JPS6165805A (ja) * 1984-09-10 1986-04-04 Nippon Ekishiyou Kk 防殺虫フイルムの製造方法
US4564614A (en) * 1984-10-11 1986-01-14 Pfizer Inc. Antiinflammatory methods
US4672061A (en) * 1985-01-28 1987-06-09 Pfizer Inc. Antiinflammatory compositions and methods
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4888343A (en) * 1986-09-15 1989-12-19 Bristol-Myers Company Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
WO1989003682A1 (en) * 1987-10-26 1989-05-05 Pfizer Inc. Benzothiazine dioxide derivatives
US5068226A (en) * 1987-12-07 1991-11-26 Cyclex, Inc. Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
CA1321192C (en) * 1988-04-20 1993-08-10 Abdul Majid Inclusion complexes of cyclodextrins by agglomeration
IT1227626B (it) * 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione

Also Published As

Publication number Publication date
AU7383891A (en) 1991-10-03
AU644417B2 (en) 1993-12-09
JPH04221314A (ja) 1992-08-11
EP0449167B1 (en) 1997-09-10
GR3025305T3 (en) 1998-02-27
IE910969A1 (en) 1991-10-09
EP0449167A1 (en) 1991-10-02
IL97693A (en) 1995-03-30
PT97176A (pt) 1991-11-29
RU2034544C1 (ru) 1995-05-10
ATE157883T1 (de) 1997-09-15
CA2039052A1 (en) 1991-09-28
US5164380A (en) 1992-11-17
CZ280164B6 (cs) 1995-11-15
FI911448A0 (fi) 1991-03-26
FI102461B (fi) 1998-12-15
HUT60738A (en) 1992-10-28
SK279171B6 (sk) 1998-07-08
NO178456B (no) 1995-12-27
HU911016D0 (en) 1991-10-28
IL97693A0 (en) 1992-06-21
FI911448A7 (fi) 1991-09-28
IT9019829A1 (it) 1991-09-27
NZ237583A (en) 1992-08-26
ES2107430T3 (es) 1997-12-01
HU217834B (hu) 2000-04-28
KR910016333A (ko) 1991-11-05
DK0449167T3 (da) 1998-03-09
PT97176B (pt) 1998-07-31
KR0175934B1 (ko) 1999-03-20
MA22089A1 (fr) 1991-10-01
IT1241088B (it) 1993-12-29
NO178456C (no) 1996-04-03
IT9019829A0 (it) 1990-03-27
DE69127566T2 (de) 1998-02-12
DE69127566D1 (de) 1997-10-16
CA2039052C (en) 2002-07-30
ZA912282B (en) 1991-12-24
NO911216L (no) 1991-09-30
FI102461B1 (fi) 1998-12-15
CS9100833A2 (en) 1991-10-15

Similar Documents

Publication Publication Date Title
NO911216D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive piroksikam/syklodekstrin-komplekser.
IL89503A0 (en) Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof
YU43694A (sh) Magnezijum omeprazol i postupak za dobijanje ovog jedinjenja
EP0214647A3 (en) Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes
ATE144523T1 (de) Glykosylierte arzneimittel-vorstufen, verfahren zu ihrer herstellung und ihre verwendungen
CA2162716A1 (en) Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use
RU95105977A (ru) Комплексы включения солей нимезулида с циклодекстринами, способ их получения, фармацевтические композиции на их основе и способ лечения
HU9203649D0 (en) Method for producing inclusion compounds of nimesulide with cyclodextrines and pharmaceutical preparatives containing these compounds
FI92195C (fi) Menetelmä terapeuttisesti käyttökelpoisten pyridiinijohdannaisten valmistamiseksi
DE59107336D1 (de) Oligosaccharidderivate und deren Verwendung in Heilmitteln
IT7920786A0 (it) Derivati della n-fenil-alanina, loro preparazione e loro impiegocome prodotti medicinali.
NL7416873A (nl) Werkwijze ter bereiding van farmaceutische pre- en met anti-allergische werking, de aldus egen gevormde voortbrengselen, alsmede ijze ter bereiding van 5:6-benzo-gamma derivaten.
EG20082A (en) Process for preparing of octadecyl-(2-N-methylpiperidino)-ethyl-phosphate
NO965267D0 (no) Glucuronyl-forbindelser, og framgangsmåte for framstilling av samme
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
IT8919543A0 (it) Derivati del 1 arilsolfonil pirrolidin 2 tione oppure del 1 arilsolfonil piperidin 2 tione, loro procedimento di preparazione e loro impiego come medicinali.
GB1531980A (en) Triazolylbenzophenone derivatives and preparation thereof
Spickes et al. Reaching Young Homemakers
IT8619969A0 (it) Derivati del ferro, procedimento per la loro produzione e relative composizioni farmaceutiche
AU483291B2 (en) Phenothiazines, process for preparing them and pharmaceutical compositions
CA790578A (en) Preparation of .delta.4,15-6,16-dimethyl-3-keto-corticosteroids and the 1-, 6-, and 1,6-dehydro derivatives thereof
CA862750A (en) Hydroxypropyl methyl cellulose ethers, a process for preparing the same, and compositions utilizing such ethers
AU7744175A (en) Phenothiazines, process for preparing them and pharmaceutical compositions
JO1822B1 (en) A new form of a compound
CA2073113A1 (en) Conjugates

Legal Events

Date Code Title Description
MK1K Patent expired